Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). (Q53540821)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). |
scientific article |
Statements
Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). (English)
1 reference
Freedman BI
1 reference
Wuerth JP
1 reference
Cartwright K
1 reference
Bain RP
1 reference
Dippe S
1 reference
Hershon K
1 reference
Mooradian AD
1 reference
Spinowitz BS
1 reference
1 October 1999
1 reference
20
1 reference
493-510
1 reference
5
1 reference
Identifiers
1 reference